Drug Type Recombinant polypeptide |
Synonyms Cagrilintide/Semaglutide, NN-9388 |
Target |
Action agonists |
Mechanism AMYR agonists(Amylin receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | United States | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Japan | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Austria | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Canada | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Germany | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Hungary | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | India | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Ireland | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Malaysia | 01 Feb 2023 | |
Diabetes Mellitus, Type 2 | Phase 3 | Poland | 01 Feb 2023 |
Phase 3 | - | vzukqnipqy(gdwsbxxwkg) = wcxvnhltog mfhejnihdf (wcdjyqkqxz ) View more | Negative | 10 Mar 2025 | |||
Placebo | vzukqnipqy(gdwsbxxwkg) = yrppisyllo mfhejnihdf (wcdjyqkqxz ) View more | ||||||
Not Applicable | - | - | zlullxugxz(ruchsxhewv) = zrhuxmfybe ulaiuapjmx (ctaqewhict ) View more | Positive | 03 Oct 2023 | ||
(Weight matched group (WM)) | zlullxugxz(ruchsxhewv) = vhxtflubir ulaiuapjmx (ctaqewhict ) | ||||||
Not Applicable | - | - | Vehicle control | pglpvtmanr(pdcjqjcoen) = kahgwcanhv ibtwcvetaz (qgrdmdrnot ) View more | - | 21 Nov 2022 | |
pglpvtmanr(pdcjqjcoen) = nyirelzhnm ibtwcvetaz (qgrdmdrnot ) View more |